Chemoresistance in gastric cancer is attributed to the overexpression of excision repair cross‐complementing 1 (ERCC1) caused by microRNA‐122 dysregulation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemoresistance in gastric cancer is attributed to the overexpression of excision repair cross‐complementing 1 (ERCC1) caused by microRNA‐122 dysregulation
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-01
DOI
10.1002/jcp.28812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer
- (2016) Cheng-Gong Hou et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development
- (2016) Bo Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric Cancer
- (2016) Shuang Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Functional SOCS3 RS115785973 Variant Regulated by MiR-4308 Promotes Gastric Cancer Development in Chinese Population
- (2016) Xiaowei Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3
- (2016) Qi Zhou et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A Functional Variant at the miR-214 Binding Site in the Methylenetetrahydrofolatereductase Gene Alters Susceptibility to Gastric Cancer in a Chinese Han Population
- (2015) Qiaoyun Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Association Between Functional PSMD10 Rs111638916 Variant Regulated by MiR-505 and Gastric Cancer Risk in a Chinese Population
- (2015) Yong Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer
- (2015) Dahu Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Altered MiRNA Expression in Gastric Cancer: a Systematic Review and Meta-Analysis
- (2015) Qi-Xian Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1
- (2015) Xiao-Jun Xiang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MicroRNA-449a Inhibits Proliferation and Induces Apoptosis by Directly Repressing E2F3 in Gastric Cancer
- (2015) Xiaoping Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-122 – A key factor and therapeutic target in liver disease
- (2015) Simonetta Bandiera et al. JOURNAL OF HEPATOLOGY
- miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells
- (2015) Hongjun Gao et al. OncoTargets and Therapy
- Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)
- (2014) Yusuf Tutar CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- miR-92a family and their target genes in tumorigenesis and metastasis
- (2014) Molin Li et al. EXPERIMENTAL CELL RESEARCH
- Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
- (2014) Weiwei Shan et al. Journal of Gynecologic Oncology
- Identification and consequences of miRNA–target interactions — beyond repression of gene expression
- (2014) Jean Hausser et al. NATURE REVIEWS GENETICS
- miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation
- (2013) Gengsheng He et al. BIOMEDICINE & PHARMACOTHERAPY
- STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells
- (2013) H-Y Lin et al. BRITISH JOURNAL OF CANCER
- Diversifying microRNA sequence and function
- (2013) Stefan L. Ameres et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance
- (2011) W Li et al. ONCOGENE
- ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation
- (2011) De Castro ONCOLOGY REPORTS
- Identification of DNA repair gene Ercc1 as a novel target in melanoma
- (2011) Liang Song et al. Pigment Cell & Melanoma Research
- Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy
- (2010) KYOUNG Ha KIM et al. APMIS
- Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection
- (2010) Hyuk-Chan KWON et al. Asia-Pacific Journal of Clinical Oncology
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone
- (2010) Corinne M. Doll et al. RADIOTHERAPY AND ONCOLOGY
- ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
- (2008) Lifeng Wang et al. BMC CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search